United States · FDA National Drug Code directory
Nabumetone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-7765_7bb2055a-93a5-448a-b44a-f120c79ab2f3
- Product NDC
- 68788-7765
- Form
- TABLET
- Composition / generic term
- Nabumetone
- Labeler
- Preferred Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200715
- Source listing expiry
- 20271231
Source-listed ingredients
- NABUMETONE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (68788-7765-1) · 68788-7765-1
- 20 TABLET in 1 BOTTLE (68788-7765-2) · 68788-7765-2
- 30 TABLET in 1 BOTTLE (68788-7765-3) · 68788-7765-3
- 60 TABLET in 1 BOTTLE (68788-7765-6) · 68788-7765-6
- 120 TABLET in 1 BOTTLE (68788-7765-8) · 68788-7765-8
- 90 TABLET in 1 BOTTLE (68788-7765-9) · 68788-7765-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →